Measures Placebo (n = 31) Betahistine (n = 31) Difference (95%CI) b
THI Change, median (IQR) 2 (-6 to 10) 4 (-4 to 14) -2 (-8 to 6)
THI Subclass, median (IQR)
Functional
6 (0 to 14)
6 (.58 to 11.44)
0 (-4 to 4)
Emotional
6 (0 to 10)
6 (-2 to 13.94)
0 (-4 to 4)
Catastrophic
0 (-8 to 14)
3.97 (-8 to 12)
0 (-8 to 8)
CGI-I, no. (%)
Very Much Improved
0 (0)
0 (0)
0 (0)
Much Improved 0 (0) 3 (9.68) 9.68 (-0.7 to 20)
Minimally Improved 2 (6.45) 6 (19.35) 12.9 (- 3.4 to 29.28)
No Change 23 (74.19) 20 (64.52) -9.68 (-32.5 to 13.15)
Minimally Worse 5 (16.13) 2 (6.45) -9.6 8 (-5.9 to 25.25)
Much Worse 1 (3.23) 0 (0) -3.22 (-9.4 to 2.93)
Very Much Worse 0 (0) 0 (0) 0 (0)
Impression of improvement, no. (%)
Yes 1 (3.23) 5 (16.13) 12,9 (- 1.46 to 27.26)
Adverse Events, no. (%) n = 30 (1 dropout) n = 27 (4 dropout)
Yes 3 (10) 8 (29.63) 19.63 (- 0.66 to 39.92)